CYDY - CytoDyn executes supply and distribution agreement with Chiral Pharma

CytoDyn ([[CYDY]]) announces that it has executed an exclusive supply and distribution agreement with Chiral Pharma to supply up to 200K vials of leronlimab to critically ill COVID-19 patients in the Philippines under Compassionate Special Permit ((CSP))authorizations."...we are using data generated from our CD12 open-label extension to pursue EUAs in multiple countries experiencing surges in critically ill COVID-19 patients," CEO Nader Pourhassan said."The Company will accelerate manufacturing of leronlimab at Samsung BioLogics upon such approval."CytoDyn had announced that the Republic of the Philippines, Department of Health, Food and Drug Administration had approved the use of leronlimab to treat a COVID-19 patient under CSP pursuant to FDA Order No. 2016-005, last month.

For further details see:

CytoDyn executes supply and distribution agreement with Chiral Pharma